These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 9738615

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Renal abscess due to Mycobacterium avium complex in a human immunodeficiency virus-positive patient.
    Colebunders R, Kint I, Bastian I, Mortelmans E, Jacobs W, Van Marck E.
    Int J Infect Dis; 2002 Sep; 6(3):238-9. PubMed ID: 12718843
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Incidence of disseminated Mycobacterium avium-complex infection in HIV patients receiving antiretroviral therapy with use of Mycobacterium avium-complex prophylaxis.
    Jung Y, Song KH, Choe PG, Park WB, Bang JH, Kim ES, Kim HB, Park SW, Kim NJ, Oh MD.
    Int J STD AIDS; 2017 Dec; 28(14):1426-1432. PubMed ID: 28592210
    [Abstract] [Full Text] [Related]

  • 27. Isolated renal Aspergillus abscess in an AIDS patient with a normal CD4+ cell count on highly active antiretroviral therapy.
    Rey D, de Mautort E, Saussine C, Hansmann Y, Waller J, Herbrecht R, Christmann D, Lindner V, Letscher-Bru V, Koenig H, Lang JM.
    Eur J Clin Microbiol Infect Dis; 1999 Feb; 18(2):137-41. PubMed ID: 10219579
    [Abstract] [Full Text] [Related]

  • 28. Mycobacterium avium complex causing endobronchial disease in AIDS patients after partial immune restoration.
    Bartley PB, Allworth AM, Eisen DP.
    Int J Tuberc Lung Dis; 1999 Dec; 3(12):1132-6. PubMed ID: 10599019
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Summaries for patients. Can maintenance therapy for opportunistic infections in HIV-infected people be stopped safely?
    Ann Intern Med; 2002 Aug 20; 137(4):I34. PubMed ID: 12186538
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy.
    Kirk O, Reiss P, Uberti-Foppa C, Bickel M, Gerstoft J, Pradier C, Wit FW, Ledergerber B, Lundgren JD, Furrer H, European HIV Cohorts.
    Ann Intern Med; 2002 Aug 20; 137(4):239-50. PubMed ID: 12186514
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Highly active antiretroviral therapy.
    French M, Lenzo N, John M, Mallal S, Price P.
    Lancet; 1998 Apr 04; 351(9108):1056-7; author reply 1058-9. PubMed ID: 9546530
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Highly active antiretroviral therapy.
    Di Perri G, Bonora S, Vento S, Allegranzi B, Concia E.
    Lancet; 1998 Apr 04; 351(9108):1056; author reply 1058-9. PubMed ID: 9546529
    [No Abstract] [Full Text] [Related]

  • 39. Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy.
    Karakousis PC, Moore RD, Chaisson RE.
    Lancet Infect Dis; 2004 Sep 04; 4(9):557-65. PubMed ID: 15336223
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.